4-thioribose nad analogues and methods of synthesizing and using the same
AssigneeUniversity of Southern California
InventorsYong Zhang, Zhefu Dai, Xiao-Nan Zhang
Life of this patent
Estimating the term…
Abstract
This disclosure provides a method of synthesis of 4′-thioribose NAD+ and analogues thereof, using an efficient chemoenzymatic approach. Also provided are methods of inhibiting the CD38 enzyme and compounds including 4′-thioribose NAD+ and compounds related thereto.
Claims21
A method of synthesizing a compound of formula I:
- or a pharmaceutically acceptable salt or solvate thereof, comprising the step of enzymatically converting a compound of formula IV:
- to the compound of formula I.
A method of synthesizing an analogue compound of formula VI:
- or a pharmaceutically acceptable salt or solvate thereof, the method comprising enzymatically converting a compound of formula VII:
- to the analogue compound of formula VI, wherein:
- X is S or O;
- R3 is selected from thymine, cytosine, adenine, uracil or guanine;
- and
- R1 and R2 are each independently selected from the group consisting of hydroxyl, thiol, optionally substituted C1-C8 alkyl, optionally substituted C1-C8 alkenyl, optionally substituted C1-C8 alkynyl, optionally substituted C1-C8 alkoxy, optionally substituted C1-C8 alkenyloxy, optionally substituted C1-C8 alkynyloxy, optionally substituted heteroaryloxy, optionally substituted aryloxy, acyl, acylamino, acyloxy, optionally substituted amino, halo, aminocarbonyl, aminothiocarbonyl, aminocarbonylamino, aminocarbonyloxy, aminosulfonyl, aminosulfonyloxy, aminosulfonylamino azidyl, cyano, nitro, oxo, amidino, arylthio, carboxylate, optionally substituted C1-C8 carboxyl ester, optionally substituted C1-C8 (carboxyl ester)amino, optionally substituted C1-C8 (carboxyl ester)oxy, optionally substituted C1-C8 cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted C1-C8 cycloalkenyl, optionally substituted C1-C8 cycloalkoxy, optionally substituted C1-C8 cycloalkylthio, optionally substituted C1-C8 cycloalkenyloxy, optionally substituted C1-C8 heterocyclyloxy, and OP wherein P is a protecting group.
A method of inhibiting enzymatic activity of CD38, comprising contacting CD38 with a compound of formula I or pharmaceutically acceptable salts and solvates thereof:
(canceled)
A compound of formula I-A and pharmaceutically acceptable salts and solvates thereof:
- wherein R3 is selected from thymine, cytosine, adenine, uracil or guanine.
19-22. (canceled)
Dependencies are inferred from the claim text.